Bevacizumab and Fingolimod Combination Therapy Induce Cytotoxicity and Apoptosis in Ovcar-3 Cells

Key Points

• To evaluate the effectiveness of Bevacizumab and Fingolimod in inducing cell death in OVCA-3 cells.
• Combination therapy of Bevacizumab and Fingolimod applied to OVCA-3 cell line
• Assessment of cytotoxicity and apoptosis rates
• Comparison of treated versus untreated control cells
• Combination increased cytotoxicity in OVCA-3 cells compared to single treatments
• Significant apoptosis observed in cells treated with both drugs
• Indication of enhanced cancer treatment efficacy through combination approach